The Oregon Clinical & Translational Research Institute (OCTRI) is pleased to announce the funding of four research awards through its Biomedical Innovation Program. The Program cultivates and selects promising translational projects that develop new biomedical devices, diagnostics, and software. Via commercialization from academia to the marketplace, the objective is to move innovative technologies to clinical application, and thus to make a meaningful impact on human health.
The Biomedical Innovation Program is a collaboration between OCTRI and OHSU Technology Transfer and Business Development (TTBD). It is supported by major funding from OCTRI, and institutional support from OHSU, with additional support from Oregon Translational Research and Development Institute (OTRADI).
Congratulations to our 2014 Biomedical Innovation Pilot Award Winners:
Minimally-invasive biomarkers to monitor treatment response in AML
Deep brain stimulation for treatment of obesity
Device to prevent posterior capsule opacification after cataract surgery
Internet Mindfulness Meditation Intervention
“Now in its second year, the Biomedical Innovation Program continues to accelerate innovation at OHSU by providing faculty with the funding, mentorship and project management necessary to develop their ideas for new biomedical devices and diagnostics,” said OCTRI Director Eric Orwoll, M.D. “We have seen outstanding progress made by the inaugural cohort of investigators and we are eager to work with the 2014 awardees as they move their technologies toward commercialization.”
Detailed information on all five awards, including project abstracts is provided on the OCTRI website.
For more information on OCTRI’s resource services, please visit: www.octri.org
OCTRI is supported by (UL1TR000128) from the National Center for Advancing Translational Science (NCATS) at the National Institutes of Health (NIH).